» Mesothelioma Chemotherapy

» Mesothelioma Survivor

» Mesothelioma Treatment Options

» Mesothelioma Risk

» Mesothelioma Survival Rate

» Mesothelioma Cancer

» Mesothelioma Facts

» Mesothelioma Resource

» Mesothelioma Lung

» Mesothelioma Compensation

» Mesothelioma Incidence

» Malignant Mesothelioma

» Benign Mesothelioma

» Pleural Mesothelioma

» Pericardial Mesothelioma

» Malignant Pleural Mesothelioma

» Mesothelioma Stage

» Mesothelioma Smoking

» Abdominal Mesothelioma

Mesothelioma Cure

     
The treatment plan for mesothelioma depends on a lot of factors, including: the stage of the cancer, where the cancer is, how far the cancer has spread, how the cancer cells look under the microscope and the patient’s age and requirements.

TIME MATTERS
People diagnosed with this sickness are often told the expected endurance rate is only eight to twelve months. However, specialists in treating spiteful mesothelioma at the leading cancer centers often have better statistics.

For instance, the five year endurance rate has approached 40% for selected patients of Dr. David Sugarbaker at Brigham and Women’s Center in Boston. To make the grade for Dr. Sugarbaker’s treatment you must meet confident criteria. One of them is being in the early stages of the disease, so time is of the essence.

Keeping way of your medical treatment is helpful and a personal medical records file can help.

TRADITIONAL CARE
There are three traditional kinds of treatment for patients with malignant mesothelioma:
• Surgery (taking out the cancer)
• Chemotherapy (using drugs to fight the cancer)
• Radiation Therapy (using high-dose x-rays or other high-energy rays to kill cancer cells)
Often two or more of these are combined in the course of treatment

MESOMARK BLOOD TEST

In January 2007, the Food and Drug Administration approved the MESOMARK assay to help monitor reply to treatment in epithelial and bi-phasic malignant mesothelioma patients. By measuring the sum of SMRP in a blood sample, doctors may be clever to better monitor a patient's evolution. The MESOMARK blood test has NOT yet been approved for the early diagnosis of mesothelioma.

This test has been permitted as a Humanitarian Use Device, meaning that physicians must follow convinced procedures to be eligible their patients for testing.

Those wishing to take part in MESOMARK testing will be asked to give one or more samples of blood.

The costs related with the MESOMARK blood test may not be enclosed under health insurance, therefore, you may be required to pay all or division of the costs out of pocket. It is recommended that you check with your insurance delivery service to determine whether coverage is existing under your policy.


» Epithelioid Mesothelioma

» International Mesothelioma

» Mesothelioma Scholarship

» Mesothelioma Memorial

» Mesothelioma Claims

» Mesothelioma Applied
   Research Foundation

» Diagnosed With Mesothelioma

» Mesothelioma Death

» Asbestos Mesothelioma

» Mesothelioma Doctor

» Asbestos Cancer    Mesothelioma

» Mesothelioma Article

» Mesothelioma Prognosis

» Accident Attorney Michigan

» Mesothelioma Diagnosis

» Mesothelioma Statistics
© 2008 All rights reserved